Identification of predictors of response to NVP-AUY922, an HSP90 inhibitor, in an in vitro panel of human non-small-cell lung cancer (NSCLC) cell lines

被引：0
|
作者：
Garon, Edward B. [2 ]
Finn, Richard S. [2 ]
Dering, Judy [2 ]
Ginther, Charles [2 ]
Adhami, Shariar [2 ]
Pitts, Sharon [2 ]
Kamranpour, Naeimeh [2 ]
Hosmer, Wylie [2 ]
Jensen, Rugaard Michael [1 ]
Quadt, Cornelia [1 ]
Slamon, Dennnis J. [2 ]
机构：
[1] Novartis Inst Biomed Res, Basel, Switzerland
[2] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S599 / S599
页数：1
相关论文
共 50 条
  • [31] HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2
    Yang, Hannah
    Lee, Mi-Hee
    Park, Intae
    Jeon, Hanwool
    Choi, Junyoung
    Seo, Seyoung
    Kim, Sang-We
    Koh, Gou Young
    Park, Kang-Seo
    Lee, Dae Ho
    CANCER LETTERS, 2017, 411 : 19 - 26
  • [32] Pharmakokinetic/phamacodynamic relationship of the HSP90 inhibitor NVP-AUY922 in human xenografts and patients in a clinical Phase I trial
    Jensen, Michael
    Ide, Susan
    Brueggen, Josef
    Schoepfer, Joseph
    Wang, Xiaofeng
    Quadt, Cornelia
    Garcia-Echeverria, Carlos
    CANCER RESEARCH, 2009, 69
  • [33] Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer
    Andree Yeramian
    Virginia García
    Laura Bergadà
    Mónica Domingo
    Maria Santacana
    Joan Valls
    Montserrat Martinez-Alonso
    José-Antonio Carceller
    Antonio Llombart Cussac
    Xavier Dolcet
    Xavier Matias-Guiu
    Molecular Imaging and Biology, 2016, 18 : 545 - 556
  • [34] NVP-AUY922, a novel diarylisoxazole resorcinol HSP90 inhibitor, potently inhibits growth and metastasis of human tumor xenografts
    Eccles, Suzanne A.
    Sharp, Swee Y.
    Raynaud, Florence I.
    Valenti, Melanie
    Patterson, Lisa
    Gowan, Sharon
    Boxall, Kathy
    Aherne, Wynne
    Rowlands, Martin
    Hayes, Angela
    Martins, Vanessa
    Urban, Federique
    Prodromou, Chrisostomos
    Pearl, Laurence
    James, Karen
    Matthews, Thomas P.
    Cheung, Kwai-Ming
    Kalusa, Andrew
    Jones, Keith
    McDonald, Edward
    Brough, Paul A.
    Massey, Andrew
    Dymock, Brian
    Drysdale, Martin
    Workman, Paul
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3522S - 3523S
  • [35] HSP90 inhibitor NVP-AUY922 exhibits the potent antiproliferative effect in gastrointestinal cancer cells with a lack of PTEN expression
    Takaoka, Munenori
    Bao, Xiaohong
    Hao, Huifang
    Fukazawa, Takuya
    Yamatsuji, Tomoki
    Tomono, Yasuko
    Sakurama, Kazufumi
    Naomoto, Yoshio
    CANCER RESEARCH, 2012, 72
  • [36] Anticancer activity of Hsp90 inhibitor AUY922 in nasopharyngeal carcinoma and non-small cell lung cancer cells
    Cho, William C.
    Wong, Chi F.
    CANCER RESEARCH, 2023, 83 (07)
  • [37] Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer
    Yeramian, Andree
    Garcia, Virginia
    Bergada, Laura
    Domingo, Monica
    Santacana, Maria
    Valls, Joan
    Martinez-Alonso, Montserrat
    Carceller, Jose-Antonio
    Llombart Cussac, Antonio
    Dolcet, Xavier
    Matias-Guiu, Xavier
    MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (04) : 545 - 556
  • [38] Phase II study of the HSP90 inhibitor AUY922 in patients with previously treated, advanced non-small cell lung cancer (NSCLC).
    Garon, Edward B.
    Moran, Teresa
    Barlesi, Fabrice
    Gandhi, Leena
    Sequist, Lecia V.
    Kim, Sang-We
    Groen, Harry J. M.
    Besse, Benjamin
    Smit, Egbert F.
    Kim, Dong-Wan
    Akimov, Mikhail
    Avsar, Emin
    Bailey, Stuart
    Felip, Enriqueta
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Novel HSP90 Inhibitor NVP-AUY922 Enhances the Anti-tumor Effect of Temsirolimus Against Oral Squamous Cell Carcinoma
    Okui, Tatsuo
    Shimo, Tsuyoshi
    Fukazawa, Takuya
    Hassan, Nur Mohammad Monsur
    Honami, Tatsuki
    Ibaragi, Soichiro
    Takaoka, Munenori
    Naomoto, Yoshio
    Sasaki, Akira
    CURRENT CANCER DRUG TARGETS, 2013, 13 (03) : 289 - 299
  • [40] Tumor cell line specific radiation response to Hsp90 inhibitors NVP-AUY922 and NVP-BEP800 added during and after irradiation
    Hartmann, S.
    Flentje, M.
    Djuzenova, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 86 - 86
12345